Nature. 2006 Dec 14;444(7121):881-7.

Abdominal obesity and metabolic syndrome.

Source

Québec Heart Institute, Hôpital Laval Research Centre, 2725 chemin Sainte-Foy, Pavilion Marguerite-D'Youville, 4th Floor, Quebec City, QC G1V 4G5, Canada. jean-pierre.despres@crhl.ulaval.ca

Abstract

Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.

PMID:: 17167477; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. [Arterioscler Thromb Vasc Biol....]
Review Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Arterioscler Thromb Vasc Biol. 2008 Jun; 28(6):1039-49. Epub 2008 Mar 20.
Review The link between abdominal obesity and the metabolic syndrome. [Curr Hypertens Rep. 2008]
Review The link between abdominal obesity and the metabolic syndrome.
Phillips LK, Prins JB. Curr Hypertens Rep. 2008 Apr; 10(2):156-64.
Review Abdominal adiposity and cardiometabolic risk: do we have all the answers? [Am J Med. 2007]
Review Abdominal adiposity and cardiometabolic risk: do we have all the answers?
Haffner SM. Am J Med. 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7.
Review Obesity and the metabolic syndrome. [Minerva Endocrinol. 2004]
Review Obesity and the metabolic syndrome.
Vega GL. Minerva Endocrinol. 2004 Jun; 29(2):47-54.
Review Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. [Expert Rev Cardiovasc Ther. 2008]
Review Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. Expert Rev Cardiovasc Ther. 2008 Mar; 6(3):343-68.

See reviews... See all...

Cited by over 100 PubMed Central articles

Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement. [Can Fam Physician. 2012]
Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement.
Chatterjee A, Harris SB, Leiter LA, Fitchett DH, Teoh H, Bhattacharyya OK. Can Fam Physician. 2012 Apr; 58(4):389-93, e196-201.
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. [PLoS One. 2012]
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice.
Chartoumpekis DV, Zaravinos A, Ziros PG, Iskrenova RP, Psyrogiannis AI, Kyriazopoulou VE, Habeos IG. PLoS One. 2012; 7(4):e34872. Epub 2012 Apr 4.
Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity. [PLoS One. 2012]
Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
Mingorance C, Duluc L, Chalopin M, Simard G, Ducluzeau PH, Herrera MD, Alvarez de Sotomayor M, Andriantsitohaina R. PLoS One. 2012; 7(3):e34268. Epub 2012 Mar 23.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Abdominal obesity and metabolic syndrome.
Abdominal obesity and metabolic syndrome.
Nature. 2006 Dec 14 ;444(7121):881-7.

PubMed
Inflammation and metabolic disorders.
Inflammation and metabolic disorders.
Nature. 2006 Dec 14 ;444(7121):860-7.

PubMed
Structural biology: dangerous liaisons on neurons.
Structural biology: dangerous liaisons on neurons.
Nature. 2006 Dec 21 ;444(7122):1019-20.

PubMed
Clinical advances in diastolic heart failure.
Clinical advances in diastolic heart failure.
Minerva Cardioangiol. 2006 Dec ;54(6):695-713.

PubMed
Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependen...
Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
J Vasc Res. 2007 ;44(1):51-60. Epub 2006 Dec 13 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: